• Join
  • Login
  • Contact

Search abstracts

Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reactions to infliximab.

  • At: Salvadore (Brazil) (2006)
  • Type: Poster
  • By: AUGUSTSSON, Jenny (Apoteket AB, Stockholm, Sweden)
  • Co-author(s): Ernestam, Sofia (Karolinska Institute, STOCKHOLM, Sweden)
    Eksborg, Staffan (Karolinska Institute, STOCKHOLM, Sweden)
    Van Vollenhoven, Ronald (Karolinska Institute, STOCKHOLM, Sweden)
  • Abstract:


    Infusion reactions are a well-described complication of infliximab (Remicade) therapy and represent the cause of appr. 15% of the discontinuations of this treatment. The aim of this study was to investigate the role of glucocorticoids and possible predictors of infusion reactions, thus improving the patient safety.



  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses